Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed Versus Flexible Dosing of Pregabalin in Fibromyalgia
NCT01226667Phase 4Completed
- Sponsor
- Osteoporosis Medical Center
- Start
- Jul 2010
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pregabalin in fibromyalgia (FM) (2 arms), sponsored by Osteoporosis Medical Center. Primary endpoint: Pain score evaluation by Numerical Rating Scale at 8 weeks. Started Jul 2010; status: completed.
02
Drugs
pregabalin
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01226667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01226667.